124 related articles for article (PubMed ID: 17658188)
1. Construction and analysis of Leishmania tarentolae transgenic strains free of selection markers.
Mureev S; Kushnir S; Kolesnikov AA; Breitling R; Alexandrov K
Mol Biochem Parasitol; 2007 Oct; 155(2):71-83. PubMed ID: 17658188
[TBL] [Abstract][Full Text] [Related]
2. Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae.
Kushnir S; Cirstea IC; Basiliya L; Lupilova N; Breitling R; Alexandrov K
Mol Biochem Parasitol; 2011 Apr; 176(2):69-79. PubMed ID: 21167214
[TBL] [Abstract][Full Text] [Related]
3. Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae.
Kushnir S; Gase K; Breitling R; Alexandrov K
Protein Expr Purif; 2005 Jul; 42(1):37-46. PubMed ID: 15939291
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies.
Bolhassani A; Taheri T; Taslimi Y; Zamanilui S; Zahedifard F; Seyed N; Torkashvand F; Vaziri B; Rafati S
Exp Parasitol; 2011 Mar; 127(3):637-45. PubMed ID: 21187086
[TBL] [Abstract][Full Text] [Related]
5. Maxicircle (mitochondrial) genome sequence (partial) of Leishmania major: gene content, arrangement and composition compared with Leishmania tarentolae.
Yatawara L; Le TH; Wickramasinghe S; Agatsuma T
Gene; 2008 Nov; 424(1-2):80-6. PubMed ID: 18718512
[TBL] [Abstract][Full Text] [Related]
6. Isotopic labeling of recombinant proteins expressed in the protozoan host Leishmania tarentolae.
Niculae A; Bayer P; Cirstea I; Bergbrede T; Pietrucha R; Gruen M; Breitling R; Alexandrov K
Protein Expr Purif; 2006 Aug; 48(2):167-72. PubMed ID: 16740394
[TBL] [Abstract][Full Text] [Related]
7. Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania tarentolae.
Soleimani M; Mahboudi F; Davoudi N; Amanzadeh A; Azizi M; Adeli A; Rastegar H; Barkhordari F; Mohajer-Maghari B
Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):55-61. PubMed ID: 17371294
[TBL] [Abstract][Full Text] [Related]
8. Specificity of modified Drosophila mariner transposons in the identification of Leishmania genes.
Augusto MJ; Squina FM; Marchini JF; Dias FC; Tosi LR
Exp Parasitol; 2004; 108(3-4):109-13. PubMed ID: 15582507
[TBL] [Abstract][Full Text] [Related]
9. Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.
Niimi T
Methods Mol Biol; 2012; 824():307-15. PubMed ID: 22160905
[TBL] [Abstract][Full Text] [Related]
10. Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.
Azizi H; Hassani K; Taslimi Y; Najafabadi HS; Papadopoulou B; Rafati S
Parasitology; 2009 Jun; 136(7):723-35. PubMed ID: 19416551
[TBL] [Abstract][Full Text] [Related]
11. Gene amplification in amphotericin B-resistant Leishmania tarentolae.
Singh AK; Papadopoulou B; Ouellette M
Exp Parasitol; 2001 Nov; 99(3):141-7. PubMed ID: 11846524
[TBL] [Abstract][Full Text] [Related]
12. [Genetic manipulation and the study of the protozoan parasite Leishmania].
Cortázar TM; Walker J
Biomedica; 2004 Dec; 24(4):438-55. PubMed ID: 15678807
[TBL] [Abstract][Full Text] [Related]
13. Translational initiation in Leishmania tarentolae and Phytomonas serpens (Kinetoplastida) is strongly influenced by pre-ATG triplet and its 5' sequence context.
Lukes J; Paris Z; Regmi S; Breitling R; Mureev S; Kushnir S; Pyatkov K; Jirků M; Alexandrov KA
Mol Biochem Parasitol; 2006 Aug; 148(2):125-32. PubMed ID: 16644031
[TBL] [Abstract][Full Text] [Related]
14. Generation of Leishmania mutants lacking antibiotic resistance genes using a versatile hit-and-run targeting strategy.
Denise H; Coombs GH; Mottram JC
FEMS Microbiol Lett; 2004 Jun; 235(1):89-94. PubMed ID: 15158266
[TBL] [Abstract][Full Text] [Related]
15. Two distinct arsenite-resistant variants of Leishmania amazonensis take different routes to achieve resistance as revealed by comparative transcriptomics.
Lin YC; Hsu JY; Shu JH; Chi Y; Chiang SC; Lee ST
Mol Biochem Parasitol; 2008 Nov; 162(1):16-31. PubMed ID: 18674569
[TBL] [Abstract][Full Text] [Related]
16. Testing the CRISPR-Cas9 and glmS ribozyme systems in Leishmania tarentolae.
Turra GL; Schneider L; Liedgens L; Deponte M
Mol Biochem Parasitol; 2021 Jan; 241():111336. PubMed ID: 33166572
[TBL] [Abstract][Full Text] [Related]
17. A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discovery.
Pineda T; Valencia Y; Flórez MF; Pulido SA; Vélez ID; Robledo SM
Parasitology; 2016 Aug; 143(9):1133-42. PubMed ID: 27174193
[TBL] [Abstract][Full Text] [Related]
18. Leishmania tarentolae for the Production of Multi-subunit Complexes.
Niimi T
Adv Exp Med Biol; 2016; 896():155-65. PubMed ID: 27165324
[TBL] [Abstract][Full Text] [Related]
19. Random transposon vectors pUTTns for the markerless integration of exogenous genes into gram-negative eubacteria chromosomes.
Li R; Wang G; Shen B; Wang R; Song Y; Li S; Jiang J
J Microbiol Methods; 2009 Nov; 79(2):220-6. PubMed ID: 19778558
[TBL] [Abstract][Full Text] [Related]
20. Replicon-free and markerless methods for genomic insertion of DNAs in phage attachment sites and controlled expression of chromosomal genes in Escherichia coli.
Chiang CJ; Chen PT; Chao YP
Biotechnol Bioeng; 2008 Dec; 101(5):985-95. PubMed ID: 18553504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
